New AAM Chief Sets Out Priorities
US Industry Body Head Says Full Promise Of Biosimilars ‘Not Being Realized’
The AAM’s new CEO, Dan Leonard, has set out his priorities for the industry association, highlighting current industry challenges as well as throwing light on how generics can be the “bridge” to a COVID-19 vaccine.
